Martin Cannon
Martin Cannon, a professor at the University of Arkansas for Medical Sciences, has been awarded a $900,000 Ovarian Cancer Research Alliance grant to study dendritic cell vaccination against ovarian cancer.
A dendritic cell is a unique immune cell that boosts immune responses by displaying antigens such as toxins or other foreign substances on its surface, triggering other immune cells such as T cells and antibody-producing B cells to respond against the antigens, according to a UAMS news release.
The grant supports a partnership between UAMS, which is serving as the lead institution, and the University of Pennsylvania in Philadelphia and MD Anderson Cancer Center at the University of Texas in Houston. The grant began in January and runs through 2023.
“The OCRA award is focused on how to overcome resistance to treatment, including dendritic cell vaccination,” Cannon said in the release, adding that the primary purpose of his study is to learn about the role certain infiltrating immune cells within an ovarian tumor play in the progression of cancer and suppression of treatment.
Sign up for Daily E-news
